According to the results of this study, the first signs of DME recurrence after DEX-I injection appear at a mean time of 5 months, suggesting that an appropriate and prudent time schedule for a PRN regimen could be limited to monthly tonometry and a first complete examination not before 4 months.
Aims: The aim of this review is to consider maxillary sinusitis as a complication of zygomatic implants placements. Maxillary sinusitis a common complication but in the literature there are no reviews that focus only on this condition and its possible treatment. This review was carried out with to highlight the main findings of the literature on this topic and to improve knowledge in this field. Methods: The search strategy resulted in 155 papers. After selection of the inclusion criteria only 11 papers were examined. From the papers these, 12.3% patients presented maxillary sinusitis but only four studies evaluated sinusitis (both clinical and radiological evaluation). The most common treatment used by the authors were antibiotics alone or combined with functional endoscopic sinus surgery (FESS). Results: The literature shows an absence of precise and shared guidelines diagnosis and post-operative follow-up, and of the treatment of maxillary sinusitis following zygomatic implantology. It has not been determined if the surgical placement of ZIs is better than the other techniques for treatment of the onset of maxillary sinusitis in the post-operative period. Conclusion: To date there are no shared protocols for maxillary sinusitis treatment. In our experience, and according to the literature in the presence of risk factors such as age, comorbidities, smoking, nasal septal deviation or other anatomical variants, we suggested that FESS is performed at the same time as placement of zygomatic implants.
Jacob’s disease is a rare entity consisting of the formation of a pseudojoint between an abnormal coronoid process of the mandible and the inner surface of the zygomatic bone. First described by Jacob in 1899, its diagnosis and definition have never been entirely univocal. In this paper, we present three emblematic cases and an extensive review of the literature on Jacob’s disease. Given the variability observed in the presentation of the disease, we have developed a proposal for the classification, here reported.
Objective: The present study was performed in order to describe how much affordable, feasible and straightforward is the approach the authors called “single stage full face surgical profileplasty”, tailored to greatly improve the surgery of the facial profiling setting and achieving a complete profile correction at the same time.
Materials and methods: From January 2010 to May 2019, 113 patients (95 females and 18 males; ages 19−63 years) were surgically treated for the full-face profile amelioration. Profile correction was performed by using a combination of five procedures out of other various previously experienced: Forehead fat grafting, Rhinoplasty, Lip fat grafting, Genioplasty and Submental Liposuction. All patients were assessed at 1, 3, 6 and 12 months following surgery for assessing the Surgical Profile Treatment (SPT) outcome and any possible side effects of the combined treatment. Facial profile stability at one year was taken as the completion point of this treatment. The Arnett’s “Soft tissue cephalometric analysis” (1999) was used to clinically evaluate the soft tissues before and after the Surgical Profile Treatment. Patients’ satisfaction was measured with the Client Satisfaction Questionnaire-8” (CSQ-8) at 3 and 12 months after surgery. Statistics were used for Arnett’s evaluation.
Results: Almost all the values were consistent and reached the normal ranges indicated by Arnett, (p<0.001) confirming that the desired results of the surgical profileplasty have been achieved.
Conclusion: Single stage full face surgical profile treatment helps in correcting faults of the global facial deformity and even in every single treated area, providing an overall improvement in face aesthetics and harmony. Obtaining the simultaneous correction in the whole face has also the advantage of avoiding multiple surgical procedures, reducing post-op discomfort and the overall risks for the patient due to multiple surgical and anesthetic procedures.
Bisphosphonates (BPs) are the most commonly used antiresorptive drugs to prevent skeletal-related events (SREs) in cancer and osteometabolic patients. A potential adverse drugs reaction associated with the administration of these drugs is Medication-related Osteonecrosis of the Jaw (MR-ONJ); its frequency in cancer patients is higher than in osteometabolic patients.
Different risk factors have been identified: drug type, duration of treatment, demographic, systemic and local factors. Among the latter, the most reported and investigated are dentoalveolar surgical procedures, anatomical factors, prosthesis and associated local oral inflammatory diseases.
To date, MR-ONJ pathophysiology remains unclear, therefore, definitive protocols on prevention in oral surgery have not been established yet.
Several studies had investigated the procedures to prevent the occurrence of MR-ONJ after oral surgery, particularly for tooth extraction. These proposed protocols included antibiotic and mouthwash treatment, atraumatic extraction, primary closure of the extraction socket, laser biostimulation and the use of autologous platelet concentrates.
The present study aimed to evaluate our one year experience in the prevention of MRONJ after dentoalveolar surgery in patients receiving bisphosphonate therapy. The protocol described and proposed by the Italian Society of Oral and Maxillofacial Surgery (SICMF) and the Italian Society of Oral Pathology and Medicine (SIPMO) has been followed; this protocol includes medical prophylaxis with strictly described surgical procedures
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.